Cancer Medicines and Chemotherapy Drugs for Hospitals and Oncology Centers
India supplies affordable generic chemotherapy medicines to more than 120 countries, and that affordability is one of the main reasons cancer treatment has become more reachable for hospitals across Africa and the Middle East over the past decade. India’s oncology drug exports were valued at approximately USD 757 million in 2019/20, and while Africa currently represents a smaller share of that trade than Europe or the Americas, demand across the region has been growing steadily as hospital oncology capacity expands.
Clinivance Healthcare Solutions supplies core chemotherapy and cancer medicines to hospitals, oncology centers and distributors across Africa and the Middle East. As an affordable and dependable supplier, we source from WHO-GMP certified Indian manufacturers, with the batch documentation and quality verification that generic oncology sourcing genuinely requires.
Our Range of Cancer Medicines
This range covers the core chemotherapy medicines hospitals order most frequently, grouped by drug class:
Taxanes
- Paclitaxel, injection / IV infusion, used in breast, ovarian, non-small-cell lung and cervical cancers
- Docetaxel, injection / IV infusion, used in breast, prostate, non-small-cell lung and gastric cancers
Platinum-Based Agents
- Cisplatin, injection / IV infusion, used in cervical, ovarian, bladder, lung, testicular and head and neck cancers
- Carboplatin, injection / IV infusion, used in ovarian, lung and other solid tumors
- Oxaliplatin, injection / IV infusion, used in colorectal and other gastrointestinal cancers
Anthracycline
- Doxorubicin, injection / IV, used in breast cancer, lymphomas, leukemias and sarcomas
Antimetabolites
- 5-Fluorouracil (5-FU), injection / IV, used in colorectal, stomach, pancreatic, breast and head and neck cancers
- Gemcitabine, injection / IV infusion, used in pancreatic, lung, breast, ovarian and bladder cancers
- Methotrexate, injection and tablet, used in acute lymphoblastic leukemia, lymphomas, osteosarcoma and breast cancer
Alkylating Agent
- Cyclophosphamide, injection / IV and tablet, used in breast cancer, lymphomas, leukemias and multiple myeloma
Vinca Alkaloids
- Vincristine, injection / IV, used in acute lymphoblastic leukemia, lymphomas and childhood cancers
- Vinblastine, injection / IV, used in Hodgkin lymphoma, other lymphomas and some solid tumors
Topoisomerase Inhibitor
- Etoposide, injection and capsule, used in small-cell lung cancer, testicular cancer, leukemias and lymphomas
Enzyme Therapy
- L-Asparaginase, injection, used in acute lymphoblastic leukemia (ALL)
Hormone Therapy
- Tamoxifen, tablet, used in hormone-receptor-positive breast cancer
India’s oncology generic industry includes several major, well established manufacturers, companies such as Cipla, Dr. Reddy’s Laboratories, Sun Pharma, Zydus Lifesciences, Intas Pharmaceuticals and Fresenius Kabi all produce oncology generics within this space, and we source from WHO-GMP certified facilities across this manufacturing network.
Quality Verification and Safe Handling
Generic oncology sourcing has a known problem globally: competition on price alone, without proper batch verification, has led to quality failures in some markets, which is exactly the kind of shortcut we do not take. Every batch comes with Certificate of Analysis and potency documentation, since cytotoxic drugs have a narrow therapeutic margin where batch consistency genuinely matters. Handling and disposal of these medicines in a healthcare facility is governed internationally by standards such as USP <800>, which sets out how hazardous and cytotoxic drugs should be received, stored, prepared and disposed of to protect staff and patients. Many injectable oncology products also require temperature-controlled storage and shipping, which we account for in how these orders are packed and transported.
Why Hospitals and Oncology Centers Choose Clinivance
Affordable does not mean unverified. We supply generic oncology medicines at competitive pricing while still holding every batch to WHO-GMP sourcing and documentation standards, so a lower price is not coming at the cost of the quality assurance your oncology department actually depends on.
The USP General Chapter <800> sets the recognized international standard for safely receiving, storing, preparing and disposing of hazardous drugs including chemotherapy medicines in healthcare settings, and it is the standard we keep in mind when advising hospitals on handling these products after delivery.
Buyers also work with us for:
- Batch-verified generic oncology medicines at competitive pricing
- Temperature-controlled packing and shipping for injectable products that require it
- Order volumes suited to hospitals, oncology centers, distributors and government tenders
- Export documentation prepared ahead of shipment arrival
Export Markets We Serve
Clinivance exports cancer medicines to hospitals, oncology centers and distributors across Africa and the Middle East, including South Africa, Kenya, Nigeria, the GCC region, Tanzania, Uganda, Ghana and Egypt. Our full Pharmaceutical Products & Generic Medicines range, including Injection & Infusion Medicines, General & Critical Care Medicines and Active Pharmaceutical Ingredients, is also available for buyers looking to consolidate orders.
Cancer Medicine Supply in South Africa, Kenya, Nigeria and the GCC
South Africa is by a wide margin the largest African destination for Indian oncology exports, valued at approximately USD 10.07 million in 2019/20, reflecting its more established private hospital oncology infrastructure. Kenya followed at approximately USD 1.67 million, with Tanzania at approximately USD 1.12 million and Uganda at approximately USD 0.24 million in the same period, according to published Indian export data. Nigeria has also become a named export market for specific oncology generics such as imatinib. Across the GCC, expanding private hospital oncology departments and medical tourism infrastructure are driving demand for a wider range of both generic and targeted cancer therapies.
We also see growing interest from Uganda, Ghana, Tanzania and Egypt as oncology treatment capacity expands, along with enquiries from distributors in parts of Asia. Unlike some other categories on our site where country data is a reasoned estimate, the figures above come from published academic research on Indian oncology export data and should be treated as historical reference points rather than current live figures.
Bulk order enquiry - Cancer Medicines
Share your requirements and receive a quote
Frequently Asked Questions
Do you supply chemotherapy medicines in bulk to hospitals and oncology centers?
Yes, we supply core chemotherapy medicines in bulk to hospitals, oncology centers, distributors and government tenders across Africa and the Middle East.
Are your cancer medicines WHO-GMP certified?
Yes, all cancer medicines are sourced from WHO-GMP certified manufacturing facilities in India, with Certificate of Analysis and batch documentation provided for every order.
How do you ensure affordable generics still meet quality standards?
We source exclusively from WHO-GMP certified manufacturers and require Certificate of Analysis and potency documentation on every batch, since generic oncology sourcing without proper verification is a known risk we specifically avoid.
Do oncology medicines require special shipping or storage?
Many injectable oncology products require temperature-controlled storage and shipping, which we account for when packing and transporting these orders. Specific requirements vary by product.
What is USP and why does it matter for these medicines?
USP <800> is a recognized international standard for safely receiving, storing, preparing and disposing of hazardous drugs, including chemotherapy medicines, in healthcare settings. It exists to protect staff and patients handling these medicines after delivery.
What documentation is provided with cancer medicine exports?
We provide WHO-GMP certificates, Certificate of Pharmaceutical Product (CoPP), Certificate of Analysis (CoA), and Free Sale Certificates to support customs clearance and local regulatory registration.
Which countries do you currently supply cancer medicines to?
We regularly export to South Africa, Kenya, Nigeria, the GCC region, Tanzania, Uganda, Ghana and Egypt, with growing interest from other Middle East markets and parts of Asia.
Can we order cancer medicines alongside other pharmaceutical products in one shipment?
Yes, most hospital and distributor orders combine cancer medicines with other pharmaceutical categories, such as general critical care medicines or injectables, into a single consolidated shipment.
Prefer to reach us directly?
enquiries@clinivanceglobal.com
Send us your product requirements
Within 24 hours
Monday – Saturday, 9AM – 6PM IST